Adolfo Moraes de Souza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Adolfo Moraes de Souza has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Juliana Ávila Duarte
Hospital de Clínicas de Porto Alegre, Brazil
6 shared publications - Matheus de Lima Ruffini
Laboratory of Molecular Psychiatry, Experimental Research Centre (CPE) and Clinical Research Centre (CPC) Hospital de Clínicas de Porto Alegre (HCPA) Porto Alegre Rio Grande do Sul Brazil
6 shared publications - Fabiano Reis
Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Radiologia e Oncologia, Campinas SP, Brazil
5 shared publications - Pedro Rodrigues Vidor
School of Medicine, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
5 shared publications - Maria Inês Schmidt
School of Medicine, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
3 shared publications - Yohan Casiraghi
School of Medicine, Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
3 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Center for Open Science in MetaArXiv
Eclipse plot: a graphical visualization for risk of bias assessments in two steps
As Cochrane’s RoB-2 has been widely adopted in systematic reviews, its traffic-light-style plot has become the standard for risk-of-bias visualization. A new risk-of-bias tool, however, introduced a two-step framework for assessing risk of bias: the ROBUST-RCT tool. Through its framework, the reviewers first evaluate what occurred in the trial (step 1) and then assess the potential impact of these events on the outcome (step 2). This paper introduces a novel visualization tool specifically designed for ROBUST-RCT, namely the “eclipse plot”, which displays both the factual evaluation and the judgment. Therefore, it aims to empower readers of systematic reviews not only to passively accept the authors' judgments but also to form their own judgments about the study’s design and conduct. Finally, consistent with the tool’s aim of simplicity, beyond the R package (“eclipseplot”), an easy-to-use web tool is also available to ensure accessibility for non-coders.
- 19 October 2026
- Published by Center for Open Science in MetaArXiv
Open AccessEclipse plot: a graphical visualization for risk of bias assessments in two steps
As Cochrane’s RoB-2 has been widely adopted in systematic reviews, its traffic-light-style plot has become the standard for risk-of-bias visualization. A new risk-of-bias tool, however, introduced a two-step framework for assessing risk of bias: the ROBUST-RCT tool. Through its framework, the reviewers first evaluate what occurred in the trial (step 1) and then assess the potential impact of these events on the outcome (step 2). This paper introduces a novel visualization tool specifically designed for ROBUST-RCT, namely the “eclipse plot”, which displays both the factual evaluation and the judgment. Therefore, it aims to empower readers of systematic reviews not only to passively accept the authors' judgments but also to form their own judgments about the study’s design and conduct. Finally, consistent with the tool’s aim of simplicity, beyond the R package (“eclipseplot”), an easy-to-use web tool is also available to ensure accessibility for non-coders.
- Open Access
- 24 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 19571
Correction: Assessing the risk of bias of clinical trials with large language models and ROBUST-RCT: a feasibility study
- 24 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 19571
Open AccessCorrection: Assessing the risk of bias of clinical trials with large language models and ROBUST-RCT: a feasibility study
- 3 April 2026
- Published by Taylor & Francis in Future Cardiology
- Vol. 22 (4) , 391-404
Granulocyte colony stimulating factor for acute myocardial infarction: an updated systematic review and meta-analysis of randomized controlled trials
Granulocyte Colony-Stimulating Factor (G-CSF) has been explored as a therapy to enhance myocardial repair after acute myocardial infarction (AMI). Earlier meta-analyses of randomized controlled trials (RCTs) reported no significant improvement but recently published studies warranted an updated synthesis. We searched PubMed, Embase, Cochrane Library, and Web of Science for RCTs comparing G-CSF with placebo or standard care in AMI. Primary outcomes were left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and left ventricular ejection fraction (LVEF). Secondary outcomes were mortality, reinfarction, restenosis, and revascularization. Eleven RCTs encompassing 1,073 participants were included. G-CSF significantly reduced LVEDV in echocardiography studies (MD: -4.39 mL; 95% CI -6.80, -1.98; p < 0.001), whereas no effect was observed in MRI studies (MD: -0.19 mL; 95% CI -7.22, 6.84; p = 0.958). LVEF improved in the echocardiography subgroup (MD: 6.76%; 95% CI 1.62, 11.90; p = 0.010) but not in the MRI subgroup (MD: -0.08%; 95% CI -2.38, 2.22; p = 0.947). LVESV showed no significant differences. No effects were seen for mortality, reinfarction, restenosis, or revascularization. G-CSF may confer structural benefits detectable by echocardiography, yet clinical outcomes remain unchanged. Larger, high-quality trials are needed to define its therapeutic role.
- 3 April 2026
- Published by Taylor & Francis in Future Cardiology
- Vol. 22 (4) , 391-404
Granulocyte colony stimulating factor for acute myocardial infarction: an updated systematic review and meta-analysis of randomized controlled trials
Granulocyte Colony-Stimulating Factor (G-CSF) has been explored as a therapy to enhance myocardial repair after acute myocardial infarction (AMI). Earlier meta-analyses of randomized controlled trials (RCTs) reported no significant improvement but recently published studies warranted an updated synthesis. We searched PubMed, Embase, Cochrane Library, and Web of Science for RCTs comparing G-CSF with placebo or standard care in AMI. Primary outcomes were left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and left ventricular ejection fraction (LVEF). Secondary outcomes were mortality, reinfarction, restenosis, and revascularization. Eleven RCTs encompassing 1,073 participants were included. G-CSF significantly reduced LVEDV in echocardiography studies (MD: -4.39 mL; 95% CI -6.80, -1.98; p < 0.001), whereas no effect was observed in MRI studies (MD: -0.19 mL; 95% CI -7.22, 6.84; p = 0.958). LVEF improved in the echocardiography subgroup (MD: 6.76%; 95% CI 1.62, 11.90; p = 0.010) but not in the MRI subgroup (MD: -0.08%; 95% CI -2.38, 2.22; p = 0.947). LVESV showed no significant differences. No effects were seen for mortality, reinfarction, restenosis, or revascularization. G-CSF may confer structural benefits detectable by echocardiography, yet clinical outcomes remain unchanged. Larger, high-quality trials are needed to define its therapeutic role.
- Open Access
- 17 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Assessing the risk of bias of clinical trials with large language models and ROBUST-RCT: a feasibility study
Risk of bias assessment is a crucial step in evidence synthesis. The traditionally adopted tool, however, is complex, resource-intensive, and unreliable. While prior investigations have focused on whether Large Language Models (LLMs) could perform assessments with RoB 2, this study is the first to evaluate the reliability of ROBUST-RCT, a novel risk-of-bias tool, as applied by humans and LLMs. Reviewers working independently used ROBUST-RCT to assess different aspects of a sample of RCTs and then reached a consensus through discussion. A chain-of-thought prompt instructed four LLMs on how to apply ROBUST-RCT. The primary analysis used Gwet’s AC2 to assess inter-rater reliability based on all the final ratings (i.e., the ratings in the second step of the tool) for all the core items of the ROBUST-RCT. A sample of 54 assessments, derived from 9 studies, was compared for each LLM against human consensus. In the primary analysis, Gwet’s AC2 inter-rater reliability varied across the LLMs. DeepSeek-R1, the lowest performer, yielded an AC2 of 0.46 ( 95% CI: 0.24 to 0.69). On the other side, Gemini 2.5 Pro Preview – the model with higher consistency with human consensus – yielded an AC2 of 0.69 (95% CI: 0.54 to 0.84). With 95% confidence, three of the four tested LLMs achieved ‘moderate’ or higher reliability based on benchmarking. LLMs could be helpful in the risk-of-bias assessment of systematic reviews using the ROBUST-RCT tool.
- 17 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessAssessing the risk of bias of clinical trials with large language models and ROBUST-RCT: a feasibility study
Risk of bias assessment is a crucial step in evidence synthesis. The traditionally adopted tool, however, is complex, resource-intensive, and unreliable. While prior investigations have focused on whether Large Language Models (LLMs) could perform assessments with RoB 2, this study is the first to evaluate the reliability of ROBUST-RCT, a novel risk-of-bias tool, as applied by humans and LLMs. Reviewers working independently used ROBUST-RCT to assess different aspects of a sample of RCTs and then reached a consensus through discussion. A chain-of-thought prompt instructed four LLMs on how to apply ROBUST-RCT. The primary analysis used Gwet’s AC2 to assess inter-rater reliability based on all the final ratings (i.e., the ratings in the second step of the tool) for all the core items of the ROBUST-RCT. A sample of 54 assessments, derived from 9 studies, was compared for each LLM against human consensus. In the primary analysis, Gwet’s AC2 inter-rater reliability varied across the LLMs. DeepSeek-R1, the lowest performer, yielded an AC2 of 0.46 ( 95% CI: 0.24 to 0.69). On the other side, Gemini 2.5 Pro Preview – the model with higher consistency with human consensus – yielded an AC2 of 0.69 (95% CI: 0.54 to 0.84). With 95% confidence, three of the four tested LLMs achieved ‘moderate’ or higher reliability based on benchmarking. LLMs could be helpful in the risk-of-bias assessment of systematic reviews using the ROBUST-RCT tool.
- Open Access
- 11 March 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (05) , 001-014
Magnetic resonance imaging in leukodystrophies: characteristic patterns and diagnostic relevance
Leukodystrophies are inherited disorders that primarily affect the central nervous system white matter and often present with nonspecific symptoms, making early diagnosis difficult. Magnetic resonance imaging (MRI) is the key initial imaging test because it reveals characteristic myelin patterns that can guide biochemical and genetic workups. To review clinically useful MRI and MR spectroscopy (MRS) patterns in major leukodystrophies and emphasize their diagnostic relevance using a practical, pattern-recognition approach. Narrative review of the literature integrating conventional MRI, including T1/T2 fluid-attenuated inversion recovery (FLAIR), and diffusion-weighted imaging (DWI), as well as advanced techniques (MRS), with a pictorial, case-based approach. The pivotal imaging distinction is between hypomyelination—diffuse, persistent T2/FLAIR hyperintensity with relative temporal stability and absent enhancement—and demyelination, characterized by confluent, progressive lesions with disorder-specific topographic predilection. Recognizable signatures include U-fiber sparing and a tigroid pattern in metachromatic leukodystrophy (MLD); parieto-occipital predominance with trizonal enhancement and restricted diffusion in X-linked adrenoleukodystrophy (X-ALD); frontal predominance and the “tadpole sign” in Alexander's disease; optic pathway and thalamic involvement in Krabbe's disease; markedly elevated N-acetylaspartate (NAA) on MRS in Canavan's disease; and tract-selective leukoencephalopathy brainstem/spinal cord involvement with a lactate peak (LBSL). These imaging clues refine differential diagnosis, guide targeted genetic testing, and support longitudinal monitoring. The use of MRI—especially when complemented by DWI and MRS—remains central for early recognition and classification of leukodystrophies. A structured, pattern-based approach integrating clinical context with imaging topography can reduce diagnostic delay and support timely management.
- 11 March 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (05) , 001-014
Open AccessMagnetic resonance imaging in leukodystrophies: characteristic patterns and diagnostic relevance
Leukodystrophies are inherited disorders that primarily affect the central nervous system white matter and often present with nonspecific symptoms, making early diagnosis difficult. Magnetic resonance imaging (MRI) is the key initial imaging test because it reveals characteristic myelin patterns that can guide biochemical and genetic workups. To review clinically useful MRI and MR spectroscopy (MRS) patterns in major leukodystrophies and emphasize their diagnostic relevance using a practical, pattern-recognition approach. Narrative review of the literature integrating conventional MRI, including T1/T2 fluid-attenuated inversion recovery (FLAIR), and diffusion-weighted imaging (DWI), as well as advanced techniques (MRS), with a pictorial, case-based approach. The pivotal imaging distinction is between hypomyelination—diffuse, persistent T2/FLAIR hyperintensity with relative temporal stability and absent enhancement—and demyelination, characterized by confluent, progressive lesions with disorder-specific topographic predilection. Recognizable signatures include U-fiber sparing and a tigroid pattern in metachromatic leukodystrophy (MLD); parieto-occipital predominance with trizonal enhancement and restricted diffusion in X-linked adrenoleukodystrophy (X-ALD); frontal predominance and the “tadpole sign” in Alexander's disease; optic pathway and thalamic involvement in Krabbe's disease; markedly elevated N-acetylaspartate (NAA) on MRS in Canavan's disease; and tract-selective leukoencephalopathy brainstem/spinal cord involvement with a lactate peak (LBSL). These imaging clues refine differential diagnosis, guide targeted genetic testing, and support longitudinal monitoring. The use of MRI—especially when complemented by DWI and MRS—remains central for early recognition and classification of leukodystrophies. A structured, pattern-based approach integrating clinical context with imaging topography can reduce diagnostic delay and support timely management.
- Open Access
- 9 March 2026
- Published by Center for Open Science in MetaArXiv
Eclipse plot: a graphical visualization for risk of bias assessments in two steps
As Cochrane’s RoB-2 has been widely adopted in systematic reviews, its traffic-light-style plot has become the standard for risk-of-bias visualization. A new risk-of-bias tool, however, introduced a two-step framework for assessing risk of bias: the ROBUST-RCT tool. Through its framework, the reviewers first evaluate what occurred in the trial (step 1) and then assess the potential impact of these events on the outcome (step 2). This paper introduces a novel visualization tool specifically designed for ROBUST-RCT, namely the “eclipse plot”, which displays both the factual evaluation and the judgment. Therefore, it aims to empower readers of systematic reviews not only to passively accept the authors' judgments but also to form their own judgments about the study’s design and conduct. Finally, consistent with the tool’s aim of simplicity, beyond the R package (“eclipseplot”), an easy-to-use web tool is also available to ensure accessibility for non-coders.
- 9 March 2026
- Published by Center for Open Science in MetaArXiv
Open AccessEclipse plot: a graphical visualization for risk of bias assessments in two steps
As Cochrane’s RoB-2 has been widely adopted in systematic reviews, its traffic-light-style plot has become the standard for risk-of-bias visualization. A new risk-of-bias tool, however, introduced a two-step framework for assessing risk of bias: the ROBUST-RCT tool. Through its framework, the reviewers first evaluate what occurred in the trial (step 1) and then assess the potential impact of these events on the outcome (step 2). This paper introduces a novel visualization tool specifically designed for ROBUST-RCT, namely the “eclipse plot”, which displays both the factual evaluation and the judgment. Therefore, it aims to empower readers of systematic reviews not only to passively accept the authors' judgments but also to form their own judgments about the study’s design and conduct. Finally, consistent with the tool’s aim of simplicity, beyond the R package (“eclipseplot”), an easy-to-use web tool is also available to ensure accessibility for non-coders.
- Open Access
- 14 November 2025
- Published by Wiley in Epileptic Disorders
- Vol. 28 (1) , 109-118
Volumetric MRI study of the brain in patients with neurocysticercosis and mesial temporal lobe epilepsy
Objective: Neurocysticercosis (NCC) is a common parasitic infection of the central nervous system and a known cause of focal epilepsy. Its potential role in triggering or contributing to mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE‐HS) is suggested, but the impact on brain volumetry remains unclear. This study aimed to assess volumetric differences in the brain, with a particular focus on the hippocampus and temporal lobes, in patients with NCC, MTLE, MTLE‐HS, and their combinations. Methods: This was an observational, cross‐sectional, retrospective, single‐center exploratory study including five groups: healthy controls; isolated MTLE; isolated NCC; MTLE‐HS; and MTLE‐HS combined with NCC (MTLE‐HS plus NCC). All participants had at least one magnetic resonance imaging (MRI) examination suitable for volumetric post‐processing. Volumetric analysis was performed on cerebral cortex regions (frontal, parietal, temporal, and occipital lobes), cerebellum, total and white matter limbic system, amygdala, hippocampus, and thalamus using the T1 MultiAtlas Segmentation tool (Brain GPS©). We also assessed sensitivity by estimating the minimum detectable difference from adjusted models and performed an exploratory analysis of NCC lesion topography with Welch t ‐tests on lobar/subcortical volumes. Results: After adjusting for age and sex, no significant group differences were found in hippocampal or temporal lobe volumetrics (all p > .10). Effect sizes were small (partial η 2 ≤ .10), and MANOVA confirmed the absence of a global effect (Pillai's Trace = .114, p = .623). Adjusted means showed only modest variation with overlapping confidence intervals, indicating that differences likely reflect individual variability rather than systematic group effects. Significance: The findings indicate that NCC, whether isolated or combined with MTLE‐HS, does not cause significant alterations in brain volume. This suggests the absence of an additive or synergistic effect of NCC on brain morphostructural changes in patients with MTLE‐HS. These results contribute to understanding the pathophysiology of epilepsy related to NCC and hippocampal sclerosis, supporting that volumetric brain changes may not underlie their association.
- 14 November 2025
- Published by Wiley in Epileptic Disorders
- Vol. 28 (1) , 109-118
Open AccessVolumetric MRI study of the brain in patients with neurocysticercosis and mesial temporal lobe epilepsy
Objective: Neurocysticercosis (NCC) is a common parasitic infection of the central nervous system and a known cause of focal epilepsy. Its potential role in triggering or contributing to mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE‐HS) is suggested, but the impact on brain volumetry remains unclear. This study aimed to assess volumetric differences in the brain, with a particular focus on the hippocampus and temporal lobes, in patients with NCC, MTLE, MTLE‐HS, and their combinations. Methods: This was an observational, cross‐sectional, retrospective, single‐center exploratory study including five groups: healthy controls; isolated MTLE; isolated NCC; MTLE‐HS; and MTLE‐HS combined with NCC (MTLE‐HS plus NCC). All participants had at least one magnetic resonance imaging (MRI) examination suitable for volumetric post‐processing. Volumetric analysis was performed on cerebral cortex regions (frontal, parietal, temporal, and occipital lobes), cerebellum, total and white matter limbic system, amygdala, hippocampus, and thalamus using the T1 MultiAtlas Segmentation tool (Brain GPS©). We also assessed sensitivity by estimating the minimum detectable difference from adjusted models and performed an exploratory analysis of NCC lesion topography with Welch t ‐tests on lobar/subcortical volumes. Results: After adjusting for age and sex, no significant group differences were found in hippocampal or temporal lobe volumetrics (all p > .10). Effect sizes were small (partial η 2 ≤ .10), and MANOVA confirmed the absence of a global effect (Pillai's Trace = .114, p = .623). Adjusted means showed only modest variation with overlapping confidence intervals, indicating that differences likely reflect individual variability rather than systematic group effects. Significance: The findings indicate that NCC, whether isolated or combined with MTLE‐HS, does not cause significant alterations in brain volume. This suggests the absence of an additive or synergistic effect of NCC on brain morphostructural changes in patients with MTLE‐HS. These results contribute to understanding the pathophysiology of epilepsy related to NCC and hippocampal sclerosis, supporting that volumetric brain changes may not underlie their association.
- Open Access
Assessment of Bias in Clinical Trials with LLMs Using ROBUST-RCT: A Feasibility Study
BACKGROUND: Bias assessment is a crucial step in evaluating evidence from randomized controlled trials. The widely adopted Cochrane RoB 2, designed to identify these issues, is complex, resource-intensive, and unreliable. Advances in artificial intelligence (AI), particularly in the field of large language models (LLMs), now allow the automation of complex tasks. While prior investigations have focused on whether LLMs could perform assessments with RoB 2, integrating technologies does not resolve the intrinsic methodological issues of the instrument. This is the first feasibility study to evaluate the reliability of ROBUST-RCT, a novel bias assessment tool, as applied by humans and LLMs. METHODS: A sample of RCTs of drug interventions was screened for eligibility. Reviewers working independently used ROBUST-RCT to assess different aspects of the studies and then reached a consensus through discussion. A chain-of-thought prompt instructed four LLMs on how to apply ROBUST-RCT. The primary analysis used Gwet’s AC2 coefficient and benchmarking to assess inter-rater reliability of the “judgment set”, defined as the series of final assessments for the six core items in the ROBUST-RCT tool. RESULTS: 54 assessments of each LLM were compared to human consensus in the primary analysis. Gwet’s AC2 inter-rater reliability ranged from 0.46 to 0.69. With 95% confidence, three of the four tested LLMs achieved ’moderate’ or higher reliability based on probabilistic benchmarking. A secondary analysis also found a Fleiss’ Kappa of 0.49 (95% CI: 0.30 – 0.60) between human reviewers before consensus, numerically higher than the values reported in prior literature about RoB 2. CONCLUSION: Large Language Models (LLMs) can effectively perform risk-of-bias assessments using the ROBUST-RCT tool, enabling their integration into future systematic review workflows aiming for enhanced objectivity and efficiency.
Open AccessAssessment of Bias in Clinical Trials with LLMs Using ROBUST-RCT: A Feasibility Study
BACKGROUND: Bias assessment is a crucial step in evaluating evidence from randomized controlled trials. The widely adopted Cochrane RoB 2, designed to identify these issues, is complex, resource-intensive, and unreliable. Advances in artificial intelligence (AI), particularly in the field of large language models (LLMs), now allow the automation of complex tasks. While prior investigations have focused on whether LLMs could perform assessments with RoB 2, integrating technologies does not resolve the intrinsic methodological issues of the instrument. This is the first feasibility study to evaluate the reliability of ROBUST-RCT, a novel bias assessment tool, as applied by humans and LLMs. METHODS: A sample of RCTs of drug interventions was screened for eligibility. Reviewers working independently used ROBUST-RCT to assess different aspects of the studies and then reached a consensus through discussion. A chain-of-thought prompt instructed four LLMs on how to apply ROBUST-RCT. The primary analysis used Gwet’s AC2 coefficient and benchmarking to assess inter-rater reliability of the “judgment set”, defined as the series of final assessments for the six core items in the ROBUST-RCT tool. RESULTS: 54 assessments of each LLM were compared to human consensus in the primary analysis. Gwet’s AC2 inter-rater reliability ranged from 0.46 to 0.69. With 95% confidence, three of the four tested LLMs achieved ’moderate’ or higher reliability based on probabilistic benchmarking. A secondary analysis also found a Fleiss’ Kappa of 0.49 (95% CI: 0.30 – 0.60) between human reviewers before consensus, numerically higher than the values reported in prior literature about RoB 2. CONCLUSION: Large Language Models (LLMs) can effectively perform risk-of-bias assessments using the ROBUST-RCT tool, enabling their integration into future systematic review workflows aiming for enhanced objectivity and efficiency.
- Open Access
- 28 July 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (11) , 001-013
Unraveling the relationship between white matter lesions in MRI and migraine: a systematic review
White matter hyperintensities (WMH) are commonly detected on brain magnetic resonance imaging (MRI) scans of migraine patients, but their clinical relevance and underlying mechanisms remain uncertain. To systematically review the relationship between WMH and migraine, focusing on prevalence, progression, and associations with clinical and demographic characteristics. We conducted a systematic review of observational studies published between 1990 and May 2025, including adult patients with migraine (with or without aura) who underwent brain MRIs with at least 1.5T scanners. Data extraction was performed by two independent reviewers, with disagreements resolved by a third. Study quality was assessed using the Newcastle-Ottawa scale for observational studies. A total of 25 studies were included, comprising approximately 3,600 participants, of whom 1,725 had migraine. Most participants were women and reported age means or medians typically between 30 and 60 years. Frequently, WMHs were observed in migraine patients, particularly in those with aura, longer disease duration, and higher headache frequency. No consistent association was found between WMH and comorbidities. Significant heterogeneity in imaging protocols, lesion quantification methods, and study design limited data comparability and precluded meta-analysis. Migraine patients often present with WMHs, but their clinical significance remains unclear. Future studies should employ standardized MRI protocols, volumetric lesion quantification, and consistent migraine phenotyping to clarify its pathophysiological role in migraine and potential implications for diagnosis and management.
- 28 July 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (11) , 001-013
Open AccessUnraveling the relationship between white matter lesions in MRI and migraine: a systematic review
White matter hyperintensities (WMH) are commonly detected on brain magnetic resonance imaging (MRI) scans of migraine patients, but their clinical relevance and underlying mechanisms remain uncertain. To systematically review the relationship between WMH and migraine, focusing on prevalence, progression, and associations with clinical and demographic characteristics. We conducted a systematic review of observational studies published between 1990 and May 2025, including adult patients with migraine (with or without aura) who underwent brain MRIs with at least 1.5T scanners. Data extraction was performed by two independent reviewers, with disagreements resolved by a third. Study quality was assessed using the Newcastle-Ottawa scale for observational studies. A total of 25 studies were included, comprising approximately 3,600 participants, of whom 1,725 had migraine. Most participants were women and reported age means or medians typically between 30 and 60 years. Frequently, WMHs were observed in migraine patients, particularly in those with aura, longer disease duration, and higher headache frequency. No consistent association was found between WMH and comorbidities. Significant heterogeneity in imaging protocols, lesion quantification methods, and study design limited data comparability and precluded meta-analysis. Migraine patients often present with WMHs, but their clinical significance remains unclear. Future studies should employ standardized MRI protocols, volumetric lesion quantification, and consistent migraine phenotyping to clarify its pathophysiological role in migraine and potential implications for diagnosis and management.
- Open Access
- 28 July 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (11) , 001-007
Testing magnetic resonance imaging parameters to predict pituitary macroadenoma consistency
Pituitary macroadenomas (PMAs) are frequently encountered tumors, predominantly characterized as soft and easily resectable during neurosurgery. In contrast, fibrous PMAs present difficulties during surgical removal. Therefore, the ability to predict the consistency of PMAs preoperatively could enhance surgical planning. To evaluate the ability of conventional T2-weighted imaging (T2WI) to predict PMA consistency by comparing isolated tumor signal intensity with the adenoma-to-middle cerebellar peduncle (ACP) ratio. Magnetic resonance imaging (MRI) scans from 45 patients with PMAs were independently reviewed by 3 blinded radiologists. For each case, the signal intensity (SI) of the adenoma and of the middle cerebellar peduncle was measured, and the ACP ratio (SIadenoma/SIpeduncle) was calculated. Tumor consistency (soft or fibrous) was determined intraoperatively by a single neurosurgeon. Intraoperative assessment classified 29 PMAs (64.4%) as soft and 16 (35.6%) as fibrous. Isolated adenoma SI on T2WI differed significantly between soft and fibrous tumors (p = 0.013), while the ACP ratio demonstrated stronger discriminatory power (p < 0.0001). The receiver operating characteristic (ROC) curve yielded an area under the curve of 0.939 for the ACP ratio. Threshold values > 1.59 were highly predictive of soft tumors (sensitivity 72.4%; specificity 100.0%), whereas values < 1.27 were associated with fibrous tumors (sensitivity 100.0%; specificity 37.5%). Although isolated adenoma SI on T2WI showed statistical significance, it was not sufficient for consistent preoperative prediction of tumor consistency. The ACP ratio provided superior accuracy and clinical utility, supporting its role as a noninvasive imaging biomarker to enhance preoperative assessment and surgical planning in patients with pituitary macroadenomas. Conceptualization: TMBC, JAD; Data curation: TMBC, JQAS, MLR, MAS; Formal analysis: TMBC, JQAS, MLR, FR; Investigation: TMBC, JQAS; Methodology: TMBC, FR, ACMA, JAD; Project administration: JAD, MMB; Supervision: ACMA, MMB, JAD; Validation: JAD; Visualization: JQAS, ACMA, MMB, JAD; Writing – original draft: TMBC, JAD, MMB; Writing – review & editing: MLR, AMS, JAD. The datasets generated and/or analyzed during the present study are available as supplementary materials accompanying the present article. Editor-in-Chief: Hélio A. G. Teive. https://orcid.org/0000-0003-2305-1073. Associate Editor: Leandro Tavares Lucato. https://orcid.org/0000-0001-9181-5245. Received: 13 June 2025 Accepted after revision: 21 September 2025 Article published online: 02 December 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
- 28 July 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (11) , 001-007
Open AccessTesting magnetic resonance imaging parameters to predict pituitary macroadenoma consistency
Pituitary macroadenomas (PMAs) are frequently encountered tumors, predominantly characterized as soft and easily resectable during neurosurgery. In contrast, fibrous PMAs present difficulties during surgical removal. Therefore, the ability to predict the consistency of PMAs preoperatively could enhance surgical planning. To evaluate the ability of conventional T2-weighted imaging (T2WI) to predict PMA consistency by comparing isolated tumor signal intensity with the adenoma-to-middle cerebellar peduncle (ACP) ratio. Magnetic resonance imaging (MRI) scans from 45 patients with PMAs were independently reviewed by 3 blinded radiologists. For each case, the signal intensity (SI) of the adenoma and of the middle cerebellar peduncle was measured, and the ACP ratio (SIadenoma/SIpeduncle) was calculated. Tumor consistency (soft or fibrous) was determined intraoperatively by a single neurosurgeon. Intraoperative assessment classified 29 PMAs (64.4%) as soft and 16 (35.6%) as fibrous. Isolated adenoma SI on T2WI differed significantly between soft and fibrous tumors (p = 0.013), while the ACP ratio demonstrated stronger discriminatory power (p < 0.0001). The receiver operating characteristic (ROC) curve yielded an area under the curve of 0.939 for the ACP ratio. Threshold values > 1.59 were highly predictive of soft tumors (sensitivity 72.4%; specificity 100.0%), whereas values < 1.27 were associated with fibrous tumors (sensitivity 100.0%; specificity 37.5%). Although isolated adenoma SI on T2WI showed statistical significance, it was not sufficient for consistent preoperative prediction of tumor consistency. The ACP ratio provided superior accuracy and clinical utility, supporting its role as a noninvasive imaging biomarker to enhance preoperative assessment and surgical planning in patients with pituitary macroadenomas. Conceptualization: TMBC, JAD; Data curation: TMBC, JQAS, MLR, MAS; Formal analysis: TMBC, JQAS, MLR, FR; Investigation: TMBC, JQAS; Methodology: TMBC, FR, ACMA, JAD; Project administration: JAD, MMB; Supervision: ACMA, MMB, JAD; Validation: JAD; Visualization: JQAS, ACMA, MMB, JAD; Writing – original draft: TMBC, JAD, MMB; Writing – review & editing: MLR, AMS, JAD. The datasets generated and/or analyzed during the present study are available as supplementary materials accompanying the present article. Editor-in-Chief: Hélio A. G. Teive. https://orcid.org/0000-0003-2305-1073. Associate Editor: Leandro Tavares Lucato. https://orcid.org/0000-0001-9181-5245. Received: 13 June 2025 Accepted after revision: 21 September 2025 Article published online: 02 December 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil